| Amyris is a synthetic biotechnology company focused on the Clean Health and Beauty markets. Co. applies its proprietary Lab-to-Market biotechnology platform to engineer, manufacture and market products. Co. does so with the use of computational tools, strain construction tools, screening and analytics tools, and lab automation and data integration. Co. produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co.'s farnesene derivatives are sold in products as nutraceuticals, skincare products, fragrances, solvents, polymers, and lubricant ingredients. The AMRS YTD return is shown above.
The YTD Return on the AMRS YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether AMRS YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the AMRS YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.